Name | squalene |
---|---|
Synonyms |
Squalene, all-trans-
(6E,10E,14E,18E)-2,6,10,15,19,23-Hexamethyltetracosa-2,6,10,14,18,22-hexaene (E,E,E,E)-Squalene 2,6,10,15,19,23-Hexamethyl-2,6,10,14,18,22-tetracosahexaene (all-E)-2,6,10,15,19,23-Hexamethyl-2,6,10,14,18,22-tetracosahexaene Squalene triacontahexaene Spinacen EINECS 203-826-1 Supraene MFCD00008912 2,6,10,14,18,22-Tetracosahexaene, 2,6,10,15,19,23-hexamethyl-, (6E,10E,14E,18E)- SQUALENE OIL SPINACENE SQUALENE WITH GC (6E,10E,14E,18E)-2,6,10,15,19,23-Hexamethyl-2,6,10,14,18,22-tetracosahexaene Squalen 2,6,10,15,19,23-Hexamethyltetracosa-(2E,6E,10E,14E,18E,22E)-2,6,10,14,18,22-hexaene trans-Spinacene |
Description | Squalene is an intermediate product in the synthesis of cholesterol, and shows several pharmacological properties such as hypolipidemic, hepatoprotective, cardioprotective, antioxidant, and antitoxicant activity. |
---|---|
Related Catalog | |
Target |
Human Endogenous Metabolite |
References |
Density | 0.8±0.1 g/cm3 |
---|---|
Boiling Point | 429.3±0.0 °C at 760 mmHg |
Melting Point | −75 °C(lit.) |
Molecular Formula | C30H50 |
Molecular Weight | 410.718 |
Flash Point | 254.1±22.2 °C |
Exact Mass | 410.391266 |
LogP | 13.09 |
Vapour Pressure | 0.0±0.5 mmHg at 25°C |
Index of Refraction | 1.492 |
Storage condition | 2-8°C |
Water Solubility | <0.1 g/100 mL at 19 ºC |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
Symbol |
GHS08 |
---|---|
Signal Word | Danger |
Hazard Statements | H304 |
Precautionary Statements | P301 + P310-P331 |
Personal Protective Equipment | Eyeshields;Gloves |
Hazard Codes | F |
Risk Phrases | R36/37/38 |
Safety Phrases | S24/25 |
RIDADR | NONH for all modes of transport |
WGK Germany | 2 |
RTECS | XB6010000 |
Packaging Group | II; III |
Hazard Class | 4.1 |
HS Code | 29012980 |
Precursor 9 | |
---|---|
DownStream 10 | |
HS Code | 2901299090 |
---|---|
Summary | 2901299090 unsaturated acyclic hydrocarbons。Supervision conditions:None。VAT:17.0%。Tax rebate rate:9.0%。MFN tariff:2.0%。General tariff:30.0% |